Literature DB >> 9714889

Enhanced gene transfer into HuH-7 cells and primary rat hepatocytes using targeted liposomes and polyethylenimine.

P Bandyopadhyay1, B T Kren, X Ma, C J Steer.   

Abstract

Different ratios of DNA phosphate to polyethylenimine amine were used for encapsulation and delivery to liver cells of chloramphenicol acetyl transferase (CAT) or luciferase expression plasmids in cationic, neutral and anionic liposomes. Positive liposomes consisted of dioleoyl phosphatidylcholine (DOPC): dioleoyl trimethylammonium propane (DOTAP) (6:1 molar ratio); neutral liposomes were composed of DOPC and dioleoyl phosphatidylethanolamine (DOPE) (1:1); and negative liposomes contained dioleoyl phosphatidylserine (DOPS) and DOPC (1:1). All formulations included 8 mol% galatocerebroside for targeting to the hepatocyte asialoglycoprotein receptor. Liposomes were prepared by film hydration followed by sequential extrusion through 0.8-0.2 mumol polycarbonate membranes. Transfection efficiency of HuH-7 human hepatoma cells and isolated rat hepatocytes was determined by CAT enzyme-linked immunosorbent assay (ELISA) or luciferase activity. Uptake of liposomal-encapsulated, fluorescently labeled 68-mer oligonucleotides was assessed by confocal microscopy. All three formulations demonstrated a twofold or greater increase in transfection efficiency and significantly lower toxicity compared to nonencapsulated polyethylenimine complexes. Negative liposomes were most effective, particularly in the rat hepatocytes. Only the cationic and anionic liposomal formulations exhibited significant thermodynamic stability. These formulations are readily characterized for size, phospholipid and DNA content, and they represent feasible systems for optimizing in vivo delivery systems to hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714889     DOI: 10.2144/98252gt03

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  8 in total

Review 1.  Targeted gene repair -- in the arena.

Authors:  Eric B Kmiec
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

2.  Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration.

Authors:  Jingmin Shu; Betsy T Kren; Zhilian Xia; Phillip Y-P Wong; Lihua Li; Eric A Hanse; Michael X Min; Bingshan Li; Jeffrey H Albrecht; Yan Zeng; Subbaya Subramanian; Clifford J Steer
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

3.  Reaction parameters of targeted gene repair in mammalian cells.

Authors:  Yiling Hu; Hetal Parekh-Olmedo; Miya Drury; Michael Skogen; Eric B Kmiec
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

4.  Quantitative dose-response curves from subcellular lipid multilayer microarrays.

Authors:  A E Kusi-Appiah; T W Lowry; E M Darrow; K A Wilson; B P Chadwick; M W Davidson; S Lenhert
Journal:  Lab Chip       Date:  2015-08-21       Impact factor: 6.799

5.  Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide.

Authors:  B T Kren; B Parashar; P Bandyopadhyay; N R Chowdhury; J R Chowdhury; C J Steer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  Targeted nucleotide repair of cyc1 mutations in Saccharomyces cerevisiae directed by modified single-stranded DNA oligonucleotides.

Authors:  Erin E Brachman; Eric B Kmiec
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

7.  Rad51p and Rad54p, but not Rad52p, elevate gene repair in Saccharomyces cerevisiae directed by modified single-stranded oligonucleotide vectors.

Authors:  Li Liu; Shuqiu Cheng; Anja J van Brabant; Eric B Kmiec
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

8.  Polyethyleneimine-modified calcium carbonate nanoparticles for p53 gene delivery.

Authors:  Cen Chen; Huafeng Han; Wei Yang; Xiaoyuan Ren; Xiangdong Kong
Journal:  Regen Biomater       Date:  2016-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.